(Bloomberg) -- Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the company still faces after its $63 billion acquisition of ...

If you’re looking for an OTC medication that’ll ease pain and quell inflammation, there are several great options to choose ...

Despite restructuring efforts, Bayer's financial outlook for 2025 remains ... patent expirations which opens competition from generic drugs. Consequently, EBITDA before special items for the ...

The ratings body Fitch hasn’t updated its review of Bayer’s debt since downgrading the group to a BBB rating in March.

Women with painful reproductive conditions say they are being pushed to take hormonal contraceptives which have damaged their ...

“Tackling back pain ... areas of the body is essential. Williams also said that most of the conventional approaches to back pain management that involve surgery or the use of drugs do not ...

Bayer has bolstered its cell ... approval and hit sales targets. CRISPR drugs can be used to modify the expression of disease-associated proteins in the body, for example, by correcting a mutation ...

The Great British Bake Off host Alison Hammond is living her happiest, healthiest life after an astonishing 150-lb weight ...

Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an $8 billion deal. Bayer first partnered with Loxo on the ...

Daniel Agger's cultured and artful defending drew comparisons to Liverpool greats soon after arriving at Anfield and if not ...